A Phase III Study of Consolidative Radiotherapy in Patients With Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA)
NCT04248452 · ACTIVE NOT RECRUITING · Phase 3
ReadTheTrial indexes 1 studies for Clinical Stage Iv Esophageal Adenocarcinoma Ajcc V8. The most common development stage is Phase 3 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
1 clinical trials found for Clinical Stage Iv Esophageal Adenocarcinoma Ajcc V8.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 3 | 1 | 100% |
There are 1 clinical trials listed for Clinical Stage Iv Esophageal Adenocarcinoma Ajcc V8. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Clinical Stage Iv Esophageal Adenocarcinoma Ajcc V8 trials are distributed across: Phase 3 (1).